Like Sun Pharma, Cipla, Glenmark Pharma: Deven Choksey

Deven Choksey of KRChoksey Invst Managers told CNBC-TV18, "Pricewise, if you look at the correction it has already happened in most of the pharmaceutical companies. I am referring to some of the frontline pharma companies. The company which we like obviously in the portfolio and we hold it is Sun Pharmaceutical Industries, Cipla and Glenmark Pharma largely. We believe that these companies have also corrected, even Dr Reddy's Laboratories included, these companies have corrected on the pricing front." "Maybe sometime correction in this year and that would become attractive to buy into the portfolio. The premium as far as the valuation is concerned has significantly come down over the market valuation. So, definitely one would like to consider buying anything available sub 20 price to earnings (PE) which would be a good opportunity at any point of time to consider," he said."We continue to hold Ramco Cements and we continue to like this particular company and buy this company at every fall. Though it is relatively premium traded, the amount of efficiency that they have demonstrated even in the wrost kind of situation as far as the profitability is concerned, I think this is one factor that is going in favour of this company.""I think this is one company that one could consider and particular during the fall in the price, it would become a good opportunity to add into the portfolio," he said.